CAROLYN WADDELL: Open Payments
NPI 1598214116 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,148 in 73 payments from 20 companies in 2025. Trend: 2023 $887 · 2024 $1,187 · 2025 $1,148
Food & beverage: $1,148
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $245 |
| ABBVIE INC. | 13 | $160 |
| Amgen Inc. | 16 | $142 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $98 |
| Janssen Pharmaceuticals, Inc | 4 | $83 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| Dexcom, Inc. | 2 | $53 |
| Novo Nordisk Inc | 3 | $49 |
| Lilly USA, LLC | 2 | $34 |
| Astellas Pharma US Inc | 1 | $31 |
Products named: NURTEC ODT, QULIPTA, XIFAXAN, SPRAVATO, ELIQUIS, EVENITY, REPATHA, TRELEGY ELLIPTA.
Industry payments across FL — which companies pay providers there.
